カテゴリ： GlobalData, アメリカ, 企業調査

Tenet Healthcare Corp (THC)-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：Tenet Healthcare Corp (THC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8014158
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月22日
◆ページ数：87
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Tenet Healthcare Corp (Tenet) is a health care services company that operates hospitals, diagnostic imaging centers, ambulatory surgery centers, and related health care facilities along with its subsidiaries and affiliates. It is one of the leading healthcare services companies in the US, with a comprehensive healthcare delivery network. The company serves urban and rural communities in US through general hospitals, including children’s hospitals, specialty hospitals, academic medical centers and critical access hospitals. Tenet’s subsidiaries provide healthcare services through several free-standing and provider-based diagnostic imaging centers, free-standing emergency department, urgent care centers and ambulatory surgery centers. It also operates private hospitals and clinics in the UK. Tenet is headquartered in Dallas, Texas, the US.

Tenet Healthcare Corp (THC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Tenet Healthcare Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Tenet Healthcare Corp, Medical Devices Deals, 2011 to YTD 2017 9
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Tenet Healthcare, Dignity Health and Ascension Health Form Joint Venture 12
Baptist Health System to Form Joint Venture with Tenet Healthcare 14
Tenet Healthcare Forms Joint Venture with United Surgical Partners 15
Debt Offering 16
Tenet Healthcare Prices Private Placement of Notes Due 2023 for USD1.9 Billion 16
Tenet Healthcare Prices Private Placement of Notes Due 2020 for USD900 Million 17
Tenet Healthcare Raises USD500 Million in Private Placement of 5% Notes Due 2019 18
Tenet Healthcare Completes Private Placement Of Notes Due 2019 For US$600 Million 19
Tenet Healthcare Completes Private Placement Of Notes Due 2022 For US$2.8 Billion 20
Tenet Healthcare Completes Private Placement Of Notes Due 2020 For US$1.8 Billion 21
Tenet Healthcare Completes Private Placement Of Notes Due 2021 For US$1.05 Billion 22
Tenet Healthcare Completes Private Placement Of Notes Due 2021 For US$850 Million 23
Tenet Healthcare Completes Private Placement Of Notes Due 2020 For US$300 Million 24
Tenet Healthcare Completes Private Placement Of Notes Due 2020 For US$500 Million 25
Tenet Healthcare Completes Private Placement Of Senior Notes Due 2020 For US$150 Million 26
Tenet Healthcare Completes Private Placement Of Senior Notes Due 2018 For US$141 Million 27
Tenet Healthcare Completes Private Placement Of Senior Secured Notes Due 2018 For US$900 Million 28
Asset Transactions 29
WellStar Health System Plans to Acquire Five Hospitals from Tenet Healthcare 29
John Muir Health Acquires 49% Stake In San Ramon Regional Medical Center From Tenet Healthcare For US$100 Million 30
Acquisition 31
Saint Louis University Acquires Saint Louis University Hospital from Tenet Healthcare 31
Tenet Healthcare Acquires Aspen Healthcare for USD214 Million 32
Tenet Healthcare Completes Acquisition of Emanuel Medical Center, Healthcare Organization 33
Tenet Healthcare to Acquire St. Mary’s Hospital 34
Tenet Healthcare Acquires Majority Stake in Texas Regional Medical Center 35
Tenet Healthcare Completes Acquisition Of Vanguard Health Systems For US$4.3 Billion 36
Conifer Health Solutions Acquires InforMed HealthCare Solutions, Information Management And Services Company 38
Tenet Healthcare Completes Acquisition Of CardioVascular Associates 39
Tenet Healthcare Corp – Key Competitors 40
Tenet Healthcare Corp – Key Employees 41
Tenet Healthcare Corp – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Joint Venture 45
Recent Developments 46
Financial Announcements 46
Nov 06, 2017: Tenet Reports Results for the Third Quarter Ended September 30, 2017 46
Oct 27, 2017: Tenet Releases Preliminary Results for the Third Quarter of 2017, Announces $150 Million Cost Reduction Initiative and Appoints New Independent Director 50
Aug 07, 2017: Tenet Reports Results for the Second Quarter Ended June 30, 2017 52
May 01, 2017: Tenet Reports Results for the First Quarter Ended March 31, 2017 54
Feb 27, 2017: Tenet Reports Results for the Fourth Quarter Ended December 31, 2016 and Issues Outlook for 2017 58
Oct 31, 2016: Tenet Reports Results for the Third Quarter Ended September 30, 2016 61
Aug 01, 2016: Tenet Reports Results for the Second Quarter Ended June 30, 2016 64
May 02, 2016: Tenet Reports Results for the First Quarter Ended March 31, 2016 67
Feb 22, 2016: Tenet Reports Results for the Fourth Quarter Ended December 31, 2015 and Issues Outlook for 2016 70
Corporate Communications 74
Nov 09, 2017: Tenet Board Appoints Two Independent Directors 74
Aug 31, 2017: Tenet Announces CEO Transition 75
Aug 31, 2017: Tenet Announces CEO Transition, Commencement of Board Refreshment Process, and Implementation of Shareholder Rights Plan to Protect NOLs 76
Aug 18, 2017: Tenet Announces Resignation of Randy Simpson and Matt Ripperger from the Board of Directors 78
Nov 11, 2016: Tenet Names Octavio Diaz, M.D., Chief Medical Officer 79
Apr 25, 2016: Tenet Appoints Tim Adams as CEO of Texas Region 80
Apr 21, 2016: Tenet Appoints Robert W. K. Webb Chief Human Resources Officer 81
Apr 07, 2016: Tenet Appoints Howard Hacker Chief Compliance Officer 82
Jan 19, 2016: Tenet Board Adds Two New Independent Directors 83
Legal and Regulatory 84
Oct 03, 2016: Tenet Healthcare Finalizes Previously Disclosed Agreement to Resolve Clinica de la Mama Investigation and Litigation 84
Oct 03, 2016: Hospital Chain Will Pay over $513 Million for Defrauding the United States and Making Illegal Payments in Exchange for Patient Referrals; Two Subsidiaries Agree to Plead Guilty 85
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87

List of Tables
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Tenet Healthcare Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Tenet Healthcare Corp, Medical Devices Deals, 2011 to YTD 2017 9
Tenet Healthcare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tenet Healthcare, Dignity Health and Ascension Health Form Joint Venture 12
Baptist Health System to Form Joint Venture with Tenet Healthcare 14
Tenet Healthcare Forms Joint Venture with United Surgical Partners 15
Tenet Healthcare Prices Private Placement of Notes Due 2023 for USD1.9 Billion 16
Tenet Healthcare Prices Private Placement of Notes Due 2020 for USD900 Million 17
Tenet Healthcare Raises USD500 Million in Private Placement of 5% Notes Due 2019 18
Tenet Healthcare Completes Private Placement Of Notes Due 2019 For US$600 Million 19
Tenet Healthcare Completes Private Placement Of Notes Due 2022 For US$2.8 Billion 20
Tenet Healthcare Completes Private Placement Of Notes Due 2020 For US$1.8 Billion 21
Tenet Healthcare Completes Private Placement Of Notes Due 2021 For US$1.05 Billion 22
Tenet Healthcare Completes Private Placement Of Notes Due 2021 For US$850 Million 23
Tenet Healthcare Completes Private Placement Of Notes Due 2020 For US$300 Million 24
Tenet Healthcare Completes Private Placement Of Notes Due 2020 For US$500 Million 25
Tenet Healthcare Completes Private Placement Of Senior Notes Due 2020 For US$150 Million 26
Tenet Healthcare Completes Private Placement Of Senior Notes Due 2018 For US$141 Million 27
Tenet Healthcare Completes Private Placement Of Senior Secured Notes Due 2018 For US$900 Million 28
WellStar Health System Plans to Acquire Five Hospitals from Tenet Healthcare 29
John Muir Health Acquires 49% Stake In San Ramon Regional Medical Center From Tenet Healthcare For US$100 Million 30
Saint Louis University Acquires Saint Louis University Hospital from Tenet Healthcare 31
Tenet Healthcare Acquires Aspen Healthcare for USD214 Million 32
Tenet Healthcare Completes Acquisition of Emanuel Medical Center, Healthcare Organization 33
Tenet Healthcare to Acquire St. Mary’s Hospital 34
Tenet Healthcare Acquires Majority Stake in Texas Regional Medical Center 35
Tenet Healthcare Completes Acquisition Of Vanguard Health Systems For US$4.3 Billion 36
Conifer Health Solutions Acquires InforMed HealthCare Solutions, Information Management And Services Company 38
Tenet Healthcare Completes Acquisition Of CardioVascular Associates 39
Tenet Healthcare Corp, Key Competitors 40
Tenet Healthcare Corp, Key Employees 41
Tenet Healthcare Corp, Other Locations 42
Tenet Healthcare Corp, Subsidiaries 43
Tenet Healthcare Corp, Joint Venture 45

★海外企業調査レポート[Tenet Healthcare Corp (THC)-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Reach Subsea ASA (REACH)：企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Driver Group Plc (DRV)：企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Incitec Pivot Ltd (IPL)：企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Heineken UK Ltd：企業の戦略・SWOT・財務情報
    Heineken UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Heineken UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BankNordik P/F：企業の戦略・SWOT・財務分析
    BankNordik P/F - Strategy, SWOT and Corporate Finance Report Summary BankNordik P/F - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Xi’an Catering Co., Ltd.：戦略・SWOT・企業財務分析
    Xi'an Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'an Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mothercare plc (MTC)：企業の財務・戦略的SWOT分析
    Mothercare plc (MTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Canon Inc.：企業の戦略・SWOT・財務情報
    Canon Inc. - Strategy, SWOT and Corporate Finance Report Summary Canon Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Oakdale Electric Cooperative：発電所・企業SWOT分析
    Oakdale Electric Cooperative – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • China Billion Resources Limited：企業の戦略・SWOT・財務情報
    China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report Summary China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nuvo Pharmaceuticals Inc (NRI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Baron Oil Plc (BOIL)：石油・ガス：M&Aディール及び事業提携情報
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • The Singing Machine Company, Inc.：戦略・SWOT・企業財務分析
    The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PVR Ltd：企業のM&A・事業提携・投資動向
    PVR Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PVR Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Celator Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • Prosafe SE (PRS)：企業の財務・戦略的SWOT分析
    Prosafe SE (PRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mega Financial Holding Co., Ltd.：企業の戦略・SWOT・財務情報
    Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • International Finance Corporation：企業の戦略的SWOT分析
    International Finance Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Clovis Oncology Inc (CLVS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆